(Q53150085)

English

Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis.

scientific article published in October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

advanced head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

Agnes L F Chan

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

Henry W C Leung

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

Shiao-Feng Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

31

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

717-726

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

Current clinical outcomes demand new treatment options for SCCHN.

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

State-of-the-art management of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Promising new advances in head and neck radiotherapy

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

The epidermal growth factor receptor mediates radioresistance.

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom.

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Definition, interpretation and calculation of cost-effectiveness acceptability curves.

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Bias in published cost effectiveness studies: systematic review

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Willingness to pay for a quality-adjusted life year: in search of a standard

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Radiochemotherapy with cetuximab, cisplatin, and amifostine for locally advanced head and neck cancer: a feasibility study

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D utility index

1 reference

https://api.crossref.org/works/10.2165%2F11588980-000000000-00000

21 January 2018

Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21744880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21744880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Introduction to health economics for physicians

1 reference

https://pubmed.ncbi.nlm.nih.gov/21744880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21744880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11588980-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

release_bv5w5fos65hulpqhmvqvpjxqru

1 reference

https://api.fatcat.wiki/v0/release/bv5w5fos65hulpqhmvqvpjxqru

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/21744880

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53150085&oldid=1837949934"